Ucb Biopharma Srl

This study is testing if giving the arthritis drug bimekizumab through an IV (into a vein) works as well as the standard injection under the skin. It will involve about 392 adults with active psoriatic arthritis or axial spondyloarthritis. The main goal is to see if the drug leve…

This study is testing a new, fast-acting inhaled form of alprazolam designed to stop prolonged seizures within 90 seconds and prevent them from coming back for several hours. It's for people aged 12 and older with epilepsy who experience these longer seizure episodes. The goal is…

This study is testing an existing adult arthritis drug called bimekizumab in children and teenagers with specific types of juvenile arthritis. The main goals are to see how much of the drug gets into the bloodstream and to check its safety when given as an injection. The trial wi…

This study is testing whether an investigational drug called bimekizumab can help control palmoplantar pustulosis, a chronic skin disease that causes painful pustules on the palms and soles. About 320 adults with moderate-to-severe symptoms will receive either the drug or a place…

This study aims to understand the long-term safety and side effects of the drug brivaracetam in children and teenagers with absence epilepsy. It will follow 120 participants who have already taken the drug in previous studies to see how well they tolerate it over an extended peri…

This study aims to see if a new injectable drug called bimekizumab works better and is as safe as an existing drug, ustekinumab, for children and adolescents with moderate to severe plaque psoriasis. It will involve about 168 participants aged 6 to 18. The main goal is to see how…

This study is testing whether a medication called rozanolixizumab is safe and effective for children aged 2 to 18 with moderate to severe generalized myasthenia gravis (gMG), a rare autoimmune disease that causes muscle weakness. The trial will enroll 12 children who haven't resp…

This study aims to understand how the drug bimekizumab behaves in the body and how safe it is for teenagers with moderate to severe hidradenitis suppurativa (HS), a painful chronic skin condition. It will enroll about 40 participants aged 12 to 18 who have not responded well to p…

This study aims to learn about the safety, drug levels in the body, and activity of an investigational drug called zilucoplan in children and teenagers (ages 2 to 18) with a rare autoimmune disease called generalized myasthenia gravis (gMG). The study will enroll about 8 particip…

This study is testing an existing drug, rozanolixizumab, in Chinese adults with generalized myasthenia gravis (gMG), a disease that causes severe muscle weakness. The main goal is to see if the drug improves patients' ability to perform daily activities and reduces their muscle w…

This study is testing an investigational drug called dapirolizumab pegol as an add-on to standard lupus medications. It aims to see if the drug can help people with moderate to severe lupus achieve long-term improvement in their disease activity and symptoms like fatigue. The tri…

This study is testing an investigational drug called galvokimig for adults with moderate-to-severe atopic dermatitis (eczema) that hasn't responded well to standard creams. Researchers will compare several doses of the drug against a placebo to see which works best at reducing sk…

This study aims to measure how much of the medication bimekizumab (Bimzelx®) passes into breast milk. It will enroll 20 breastfeeding mothers who are already using this drug to treat conditions like psoriasis or arthritis. Researchers will collect breast milk samples over several…

This is an early-stage study to check the safety and how the body processes a new oral drug called UCB0022 (glovadalen). It will involve 32 healthy adult volunteers from Caucasian, Japanese, and Chinese backgrounds. The main goal is to see what side effects occur and how the drug…

This is the first human study for a new drug called UCB5285. Researchers will give increasing doses to 96 healthy volunteers to check for side effects and see how the drug moves through the body. The main goal is to determine if the drug is safe enough to test in future studies w…

This study aims to understand how the medication bimekizumab affects specific genes in the skin of people with moderate to severe plaque psoriasis. It will involve about 90 participants, some of whom also have psoriatic arthritis. Researchers will take small skin samples to measu…